1. Home
  2. EVH vs BBNX Comparison

EVH vs BBNX Comparison

Compare EVH & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$6.20

Market Cap

469.0M

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.86

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
BBNX
Founded
2011
2015
Country
United States
United States
Employees
N/A
423
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.0M
493.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
EVH
BBNX
Price
$6.20
$16.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
10
Target Price
$7.93
$23.80
AVG Volume (30 Days)
2.3M
943.7K
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$907,957,000.00
N/A
Revenue This Year
$33.89
$34.90
Revenue Next Year
$15.84
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$8.80
52 Week High
$11.81
$32.71

Technical Indicators

Market Signals
Indicator
EVH
BBNX
Relative Strength Index (RSI) 72.28 64.29
Support Level $3.67 $16.02
Resistance Level $8.30 $32.52
Average True Range (ATR) 0.37 1.10
MACD 0.03 -0.04
Stochastic Oscillator 95.61 81.77

Price Performance

Historical Comparison
EVH
BBNX

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: